The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha.
Open accessAbstract
Insulin resistance is an important metabolic abnormality often associated with infections, cancer, obesity, and especially non-insulin-dependent diabetes mellitus (NIDDM). We have previously demonstrated that tumor necrosis factor-alpha produced by adipose tissue is a key mediator of insulin resistance in animal models of obesity-diabetes. However, the mechanism by which TNF-alpha interferes with insulin action is not known. Since a defective insulin receptor (IR) tyrosine kinase activity has been observed in obesity and NIDDM, we measured the IR tyrosine kinase activity in the Zucker (fa/fa) rat model of obesity and insulin resistance after neutralizing TNF-alpha with a soluble TNF receptor (TNFR)-lgG fusion protein. This neutralization resulted in a marked increase in insulin-stimulated autophosphorylation of the IR, as well as phosphorylation of insulin receptor substrate 1 (IRS-1) in muscle and fat tissues of the fa/fa rats, restoring them to near control (lean) levels. In contrast, no significant changes were observed in insulin-stimulated tyrosine phosphorylations of IR and IRS-1 in liver. The physiological significance of the improvements in IR signaling was indicated by a concurrent reduction in plasma glucose, insulin, and free fatty acid levels. These results demonstrate that TNF-alpha participates in obesity-related systemic insulin resistance by inhibiting the IR tyrosine kinase in the two tissues mainly responsible for insulin-stimulated glucose uptake: muscle and fat.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several animal models of obesity and insulin resistance show significantly higher levels of TNF␣ mRNA and protein compared with their lean counterparts (47-49)”
From Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle (2005) · cites this paper as [47]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,311
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Self-citationElective induction versus spontaneous labor after sonographic diagnosis of fetal macrosomia.
Combs, C. A., Singh, N. B., & Khoury, J. C. (1993) · PubMed · Cited by 2,463
White, M. F., & Kahn, C. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42297-6 · Cited by 1,707
Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., & White, M. F. (1991) · Nature · doi:10.1038/352073a0 · Cited by 1,574
Tumor necrosis factor alpha inhibits signaling from the insulin receptor.
Hotamışlıgil, G. S., Murray, D. L., Choy, L., & Spiegelman, B. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4854 · Cited by 1,220
Self-citationInsulin Stimulates the Phosphorylation of the 95,000-Dalton Subunit of Its Own Receptor
Kasuga, M., Karlsson, F. A., & Kahn, C. R. (1982) · Science · doi:10.1126/science.7031900 · Cited by 1,132
Insulin Resistance — Mechanisms, Syndromes, and Implications
Epstein, F. H., Moller, D. E., & Flier, J. S. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251307 · Cited by 807
Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells
White, M. F., Maron, R., & Kahn, C. R. (1985) · Nature · doi:10.1038/318183a0 · Cited by 642
Flagged first, then by citations
Research works printed but not linked: 3
- Moller, D. E. 1993. Insulin Resistance. John Wiley and Sons Ltd., UK.
- Hotamisligil, G. S., D. L. Murray, L. N. Choy, and B. M. Spiegelman. 1994. TNF-a inhibits signaling from insulin receptor. Proc. Natl. Acad. Sci. USA. 91:4854-4858.
- Cotran, R. S., V. Kumar, and S. L. Robbins, editors. 1989. Pathological Basis of Disease. 4th edition. W.B. Saunders Company, Philadelphia, PA. 22- 23.
Cited by
Sorted by citations
Items 501–600 of 816
van Greevenbroek, M. M. J., Kallen, C., Geurts, J. M. W., Janssen, R. G. J. H., Buurman, W. A., & de Bruin, T. W. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00375-0 · Cited by 20
Incretin-based therapeutics for the treatment of neurodegenerative diseases
Vear, A., Heneka, M. T., & Clemmensen, C. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01263-4 · Cited by 25
Associations Between Asthma and Polycystic Ovary Syndrome: Current Perspectives
Xu, Y., Zhou, Z., Pan, J., & Huang, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.936948 · Cited by 19
Ruan, G., Shi, J., Xie, H., Zhang, H., Zhao, H., Liu, X., Ge, Y., Zhang, X., Yang, M., Zhu, L., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1394892 · Cited by 19
Ezhumalai, M., Ashokkumar, N., & Pugalendi, K. V. (2014) · Biochimie · doi:10.1016/j.biochi.2014.12.005 · Cited by 19
RetractedPerpetuating effects of androgen deficiency on insulin resistance
Cameron, J. L., Jain, R., Rais, M., White, A. E., Beer, T. M., Kievit, P., Winters‐Stone, K. M., Messaoudi, I., & Varlamov, O. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.148 · Cited by 19
Montazeri, S., Nalliah, S., & Radhakrishnan, A. K. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.01.028 · Cited by 19
Sakurai, T., Takei, M., Ogasawara, J., Watanabe, N., Sampei, M., Yoshida, M., Nakae, D., Sakurai, T., Nakano, N., Kizaki, T., et al. (2005) · The Japanese Journal of Physiology · doi:10.2170/jjphysiol.r2096 · Cited by 20
Yang, H. S., Choi, Y. J., Jin, H. Y., Lee, S. C., & Huh, C.-K. (2016) · Food Science and Biotechnology · doi:10.1007/s10068-016-0086-7 · Cited by 20
Therapeutic applications of conditioned medium from adipose tissue
Dai, M., Zhang, Y., Yu, M., & Tian, W. (2016) · Cell Proliferation · doi:10.1111/cpr.12281 · Cited by 19
Tobin, B. W., Leeper-Woodford, S. K., Hashemi, B. B., Smith, S. M., & Sams, C. F. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.1.e92 · Cited by 19
TNF-α and insulin resistance: Summary and future prospects
Peraldi, P., & Spiegelman, B. M. (1998) · Springer eBooks · doi:10.1007/978-1-4615-5647-3_18 · Cited by 22
Self-citationLionetti, L., Sica, R., Mollica, M. P., & Putti, R. (2013) · Food and Nutrition Sciences · doi:10.4236/fns.2013.49a1017 · Cited by 19
Sethiya, N. K., Ghiloria, N., Srivastav, A., Bisht, D., Chaudhary, S. K., Walia, V., & Alam, M. S. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230718105358 · Cited by 20
Preventive pharmacotherapy in type 2 diabetes mellitus
Kalra, S., Choudhary, N., Unnikrishnan, A., & Ajish, T. (2011) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.91183 · Cited by 18
Nakagawa, T., Goto, H., Hussein, G. M. E., HIKIAMI, H., Shibahara, N., & Shimada, Y. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.11.019 · Cited by 18
Shaaban, D., & Al-Mutairi, N. (2018) · Journal of Dermatological Treatment · doi:10.1080/09546634.2016.1254145 · Cited by 18
Alipourfard, I., Bakhtiyari, S., Gheysarzadeh, A., Renzo, L. D., LORENZO, A. D., Mikeladze, D., & Khamoushi, A. (2020) · Current Molecular Medicine · doi:10.2174/1566524020666200427102209 · Cited by 18
Koufakis, T., Dimitriadis, G., Metallidis, S., Zebekakis, P. E., & Kotsa, K. (2021) · Obesity Reviews · doi:10.1111/obr.13231 · Cited by 19
Blood glucose regulation in context of infection
Wensveen, F. M., Šestan, M., Wensveen, T. T., & Polić, B. (2021) · Vitamins and hormones · doi:10.1016/bs.vh.2021.06.009 · Cited by 20
Effect of infliximab on metabolic disorders induced by Walker-256 tumor in rats
Miksza, D. R., de Souza, C. O., de Morais, H., da Rocha, A. F., Borba‐Murad, G. R., Bazotte, R. B., & de Souza, H. M. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71077-6 · Cited by 17
Morrison, J. A., BARTON, B. A., Biro, F. M., & Sprecher, D. L. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90233-5 · Cited by 17
Fukunishi, S., Nishio, H., Fukuda, A., Takeshita, A., Hanafusa, T., Higuchi, K., & Suzuki, K. (2009) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.09-50 · Cited by 16
Type 2 diabetes mellitus, resistance training, and innate immunity: is there a common link?
Dipenta, J. M., Green-Johnson, J. M., & Murphy, R. J. L. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-094 · Cited by 17
Siddiqui, K., Joy, S. S., & George, T. P. (2020) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2020.100059 · Cited by 17
Ling, W., Higashiura, K., Ura, N., Miura, T., & Shimamoto, K. (2003) · Hypertension Research · doi:10.1291/hypres.26.527 · Cited by 16
Lin, S.-Y., Wang, Y.-Y., & Sheu, W. H. (2004) · Metabolism · doi:10.1016/j.metabol.2004.01.016 · Cited by 16
Lacerda, L., Opie, L. H., & Lecour, S. (2012) · Experimental Diabetes Research · doi:10.1155/2012/502654 · Cited by 15
Lamichhane, R., Pandeya, P. R., Lee, K., Kim, S.-G., Devkota, H. P., & Jung, H. (2020) · Molecules · doi:10.3390/molecules25061337 · Cited by 15
Šalamun, V., Rizzo, M., Lovrečić, L., Hočevar, K., Papler, T. B., Janež, A., Jensterle, M., Bokal, E. V., Peterlin, B., & Maver, A. (2022) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2021.0149 · Cited by 16
Wang, J., Cheung, A. T., Kolls, J. K., Starks, W. W., Martinez‐Hernandez, A., Dietzen, D. J., & Bryer‐Ash, M. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00173.x · Cited by 15
Signalling Networks Governing Metabolic Inflammation
Dali‐Youcef, N., & Ricci, R. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_4 · Cited by 14
Harper, J. W., Welch, M. P., D, M. N. S. M., Wahbeh, G. T., & Lee, S. D. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04915.x · Cited by 14
Inflammation in human adipose tissues–Shades of gray, rather than white and brown
Rakotoarivelo, V., Variya, B. C., Ilangumaran, S., Langlois, M., & Ramanathan, S. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.10.001 · Cited by 14
Hu, W., Fan, X., Zhou, B., Li, L., Tian, B., Xia, F., Xu, X., Liu, H., Yang, G., & Liu, Y. (2019) · Medicine · doi:10.1097/md.0000000000016428 · Cited by 14
Comorbidities in patients with palmoplantar plaque psoriasis
Greenberg, R., Goldsmith, T., Zeltser, D., Shapira, I., Berliner, S. A., Rogowski, O., Shenhar‐Tsarfaty, S., Sprecher, E., & Matz, H. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.03.112 · Cited by 14
Chu, N., Shen, M., Wu, D., & Shieh, S. (2002) · Clinical Biochemistry · doi:10.1016/s0009-9120(02)00314-4 · Cited by 14
Tumor necrosis factor-α as a mediator of the insulin resistance of obesity
Rosen, E. D., & Spiegelman, B. M. (1999) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-199904000-00014 · Cited by 14
Self-citationEcstasy (MDMA) in Recreational Users: Self-Reported Psychological and Physiological Effects
DAVISON, D., & Parrott, A. C. (1997) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199705/06)12:3 · Cited by 134
Sermikli, B. P., Aydoğdu, G., & Yılmaz, E. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05665-3 · Cited by 13
Chemerin as a Driver of Cardiovascular Diseases: New Perspectives and Future Directions
Imiela, A. M., Stępnicki, J., Zawadzka, P. S., Bursa, A., & Pruszczyk, P. (2025) · Biomedicines · doi:10.3390/biomedicines13061481 · Cited by 16
Bal, Y., Adaş, M., & Helvacı, A. (2010) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03657354 · Cited by 13
Lou, P., Lucchinetti, E., Wawrzyniak, P., Morsy, Y., Wawrzyniak, M., Scharl, M. M., Krämer, S. D., Rogler, G., Hersberger, M., & Zaugg, M. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000412 · Cited by 13
Use of Insulin to Improve Glycemic Control in Diabetes Mellitus
Dandona, P., Chaudhuri, A., Ghanim, H., & Mohanty, P. (2008) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-008-6101-3 · Cited by 13
Discovery and Development of a New Insulin Sensitizing Agent, Pioglitazone
Sohda, T., KAWAMATSU, Y., Fujita, T., Meguro, K., & Ikeda, H. (2002) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.122.909 · Cited by 13
Tumour Necrosis Factor-α Levels in Non-Diabetic Offspring of Patients with Type 2 Diabetes Mellitus
Maltezos, E. S., Papazoglou, D., Exiara, T., Papazoglou, L., Karathanasis, E., Christakidis, D., & Ktenidou-Kartali, S. (2002) · Journal of International Medical Research · doi:10.1177/147323000203000605 · Cited by 11
Tigno, X. T., Ding, S. Y., & HANSEN, B. C. (2006) · PubMed · Cited by 13
Muscari, A., Martignani, C., Bastagli, L., Poggiopollini, G., Tomassetti, V., Baldini, L., Cappelletti, O., Boni, P., Ravaglia, G., & Puddu, P. (2003) · European Journal of Vascular and Endovascular Surgery · doi:10.1053/ejvs.2002.1879 · Cited by 13
TNFα-induced DLK activation contributes to apoptosis in the beta-cell line HIT
Börchers, S., Babaei, R., Klimpel, C., Escobar, J. D., Schröder, S., Blume, R., Malik, M. N. H., & Oetjen, E. (2017) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-017-1385-0 · Cited by 12
Lopreiato, V., Hosseini, A., da Rosa, F. T., Zhou, Z., Alharthi, A. S., Trevisi, E., & Loor, J. J. (2018) · Journal of Dairy Science · doi:10.3168/jds.2018-14389 · Cited by 12
Effects of Adalimumab, an Anti-tumour Necrosis Factor-Alpha (TNF-α) Antibody, on Obese Diabetic Rats
Shuwa, H. A., Dallatu, M. K., Yeldu, M. H., Ahmed, H., & Abdullahi, I. N. (2018) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2018.25.4.5 · Cited by 12
Ameen, E. M., & Mohammed, H. Y. (2022) · Iraqi Journal of Science · doi:10.24996/ijs.2022.63.8.7 · Cited by 12
Adipose inflammation: cause or consequence of obesity-related insulin resistance
Xu, H. (2008) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s4180 · Cited by 12
Clinical Outcomes in Metabolic Syndrome
Bhatheja, R., & Bhatt, D. L. (2006) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-200607000-00011 · Cited by 12
Identification of specific sites in the TNF-α molecule promoting insulin resistance in H-411E cells
Solomon, S. S., Mishra, S. K., Palazzolo, M. R., Postlethwaite, A. E., & Seyer, J. M. (1997) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(97)90090-1 · Cited by 12
Fagerberg, B., Behre, C. J., Wikstrand, J., Hultén, L. M., & Hulthe, J. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510701870898 · Cited by 12
Yorulmaz, H., Kaptan, E., Şeker, F. B., & Öztaş, B. (2015) · Cell Biochemistry and Function · doi:10.1002/cbf.3113 · Cited by 12
Berk, P. D., Zhou, S., Bradbury, M., Stump, D. D., Kiang, C. L., & Isola, L. M. (1997) · PubMed Central · Cited by 12
Peikert, A., Vacca, A., Norata, G. D., Schiattarella, G. G., & Osto, E. (2026) · Circulation Heart Failure · doi:10.1161/circheartfailure.125.012674 · Cited by 16
Wang, S., Wang, S., & Lee, K. T. (2011) · Gastroenterology Research and Practice · doi:10.1155/2011/215986 · Cited by 11
Liu, Y., Wang, X., Zhao, Y., Zhao, P., Wang, L., Zhai, Q., Zhang, X., Tian, W., Xiang, X., & Li, T. (2017) · Journal of Diabetes Research · doi:10.1155/2017/4802319 · Cited by 11
Abhilasha, Mitra, P., Suri, S., Saxena, I., Shukla, R. K. G., Shukla, K. K., & Sharma, P. (2021) · Gene Reports · doi:10.1016/j.genrep.2021.101251 · Cited by 11
Toda, K., Hayashi, Y., & Saibara, T. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.03.002 · Cited by 11
Wu, S., Dong, K., Wang, J., & Bi, Y. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej17-0539 · Cited by 12
Tripp, M. L., Darland, G. K., Konda, V. R., Pacioretty, L. M., Chang, J., Bland, J. S., & Babish, J. G. (2012) · Nutrition Research and Practice · doi:10.4162/nrp.2012.6.5.405 · Cited by 11
Ingenbleek, Y. (2010) · The Open Clinical Chemistry Journal · doi:10.2174/1874241600902010049 · Cited by 10
Endothelin-Stimulated Ca2+Mobilization by 3T3-L1 Adipocytes Is Suppressed by Tumor Necrosis Factor-α
Yorek, M. A., Jaipaul, N., Dunlap, J. A., & Bielefeldt, K. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0982 · Cited by 11
Anuurad, E., Tracy, R. P., Pearson, T. A., Beckett, L. A., & Berglund, L. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.10.016 · Cited by 11
Cell volume and the metabolic actions of insulin
Zhande, R., & Brownsey, R. W. (1996) · Biochemistry and Cell Biology · doi:10.1139/o96-055 · Cited by 11
Soltani, S., Aminianfar, A., Hajianfar, H., Azadbakht, L., Shahshahan, Z., & Esmaillzadeh, A. (2021) · Nutrition Journal · doi:10.1186/s12937-021-00705-5 · Cited by 10
Noninvasive biochemical markers and surrogate scores in evaluating nonalcoholic steatohepatitis
Elsayed, A., Ismaiel, A., Procopio, A. C., Luzza, F., Abenavoli, L., & Dumitrascu, D. L. (2022) · Minerva Medica · doi:10.23736/s0026-4806.22.08185-x · Cited by 10
Publisher, B. S. P. B. S. (2006) · Current Vascular Pharmacology · doi:10.2174/157016106778521599 · Cited by 9
Wong, V. S. C., Szeto, L., Uffelman, K. D., Fantus, I. G., & Lewis, G. F. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06396 · Cited by 10
Hamlat, N., Forcheron, F., Neggazi, S., del Carmine, P., Feugier, P., Bricca, G., Bouguerra, S. A., & Beylot, M. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-64 · Cited by 12
Langhans, W., & Hrupka, B. J. (2003) · Neurobiological foundation of aberrant behaviors · doi:10.1007/978-1-4615-0323-1_9 · Cited by 10
Ko, W. C., Liu, T. P., Cheng, J., Tzeng, T., & Liu, I.-M. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.047 · Cited by 10
Sphingomyelinase has an insulin-like effect on glucose transporter translocation in adipocytes
David, T. S., Ortiz, P. A., Smith, T., & Turinsky, J. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.5.r1446 · Cited by 10
Cytokines in diseases of the endocrine system
Igaz, P., Falus, A., Gláz, E., & Rácz, K. (2000) · Cell Biology International · doi:10.1006/cbir.2000.0536 · Cited by 9
Neuroinflammation in diabetic peripheral neuropathy and therapeutic implications
Chong, Z. Z., & Souayah, N. (2025) · Reviews in the Neurosciences · doi:10.1515/revneuro-2025-0031 · Cited by 9
Gastric bypass surgery alters the mechanisms of insulin resistance in the adipose tissue of GK rats
Li, J., Wang, Y., Zhou, Y., & Liu, J. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1053 · Cited by 9
Cytokines and Insulin Resistance after Zoledronic Acid-Induced Acute Phase Response
Kassi, G., Papamichael, K., Papaioannou, G., Giagourta, I., Thanou, S., Triantaphyllopoulou, M., Zapanti, E., Papandroulaki, F., Ktena, V., & Karga, H. (2014) · Immunological Investigations · doi:10.3109/08820139.2014.892510 · Cited by 9
Disease model: hyperinsulinemia and insulin resistance Part B – polygenic and other animal models
Sone, H., Takahashi, A., Iida, K., & Yamada, N. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02072-x · Cited by 9
Age-related changes in insulin receptor mRNA and protein expression in genetically obese Zucker rats
Amessou, M., Tahiri, K., Chauvet, G., & Desbuquois, B. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.09.004 · Cited by 9
Yorek, M. A., Dunlap, J. A., & Lowe, W. L. (1998) · Biochemical Journal · doi:10.1042/bj3360317 · Cited by 9
Zahorska‐Markiewicz, B., Olszanecka‐Glinianowicz, M., Janowska, J., & Kocełak, P. (2008) · PubMed · Cited by 9
Stress-hyperglycemia, insulin and immunomodulation in sepsis
Marik, P. E., & Raghavan, M. (2007) · Springer eBooks · doi:10.1007/3-540-37363-2_36 · Cited by 9
Obesity and Type-2 Diabetes in the Elderly
Dewan, S., & Wilding, J. P. H. (2003) · Gerontology · doi:10.1159/000069176 · Cited by 9
Dehydroepiandrosterone alters lipid profiles in Zucker rats
Abadie, J. M., Malcom, G. T., Porter, J. R., & Svec, F. (2000) · Lipids · doi:10.1007/s11745-000-0564-4 · Cited by 9
Regulation of Glucose Transporters - Implications for Insulin Resistance States
Tirosh, A., Rudich, A., & Bashan, N. (2000) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2000.13.2.115 · Cited by 9
Stress-hyperglycemia, insulin and immunomodulation in sepsis
Marik, P. E., & Raghavan, M. (2009) · Springer eBooks · doi:10.1007/978-3-642-01769-8_43 · Cited by 9
Alterations in Fuel Metabolism in Critical Illness
Mizoch, B. A. (1997) · Humana Press eBooks · doi:10.1007/978-1-4757-2584-1_10 · Cited by 9
Holden, R. J., & Pakula, I. S. (1995) · Medical Hypotheses · doi:10.1016/0306-9877(95)90242-2 · Cited by 9
Prevalencia del síndrome metabólico (SM) en pacientes con psoriasis
Hernández, C. J. E., Niebla, R. M. L., López, M. E. S., Kresch‐Tronik, N. S., & Memije, M. E. V. (2014) · Gaceta Médica de México · Cited by 8
Wu, Y., Zhao, R., Li, H., Li, H., Chen, Z., & Zhao, Y. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2022.06.014 · Cited by 8
The interrelationship of depression and diabetes
Musselman, D. L., Bowling, A., Gilles, N., Larsen, H., Betan, E. J., & Phillips, L. S. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544293.009 · Cited by 8
Underlying Pathways for Interferon Risk to Type II Diabetes Mellitus
Abdel‐Hamid, N. M., Jubori, T., Farhan, A., Mahrous, M., Gouri, A., Awad, E. M., & Breuss, J. M. (2013) · Current Diabetes Reviews · doi:10.2174/15733998113096660080 · Cited by 8
Eberle, K. C., Waters, T. E., Jensen, E. D., Venn-Watson, S. K., & Sacco, R. E. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00134 · Cited by 8
Merchant, A. T., Nahhas, G. J., Wadwa, R. P., Zhang, J., Tang, Y., Johnson, L. R., Maahs, D. M., Bishop, F. K., Teles, R. P., & Morrato, E. H. (2015) · Journal of Periodontology · doi:10.1902/jop.2015.150531 · Cited by 9
Eckel, J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809518-8.00002-7 · Cited by 11
Xia, Z., Su, Y., Petersen, P. S., Qi, L., Kim, A. E., Figueiredo, J. C., Lin, Y., Nan, H., Sakoda, L. C., Albanes, D., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.2971 · Cited by 8
Metadata
- Authors
- Hotamisligil, G. S., Budavari, A., Murray, D., & Spiegelman, B. M.
- Affiliations
- Harvard University (US)
- ORCID
- Spiegelman, B M
- Venue
- Journal of Clinical Investigation
- Published
- 1994-10-01
- Volume
- 94
- Issue
- 4
- Pages
- 1543-1549
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC295304
- OpenAlex
- W2053200285
- Cited by
- 819
- References
- 29
- Citations by year
- 2026: 8 · 2025: 20 · 2024: 14 · 2023: 13 · 2022: 23 · 2021: 22 · 2020: 26 · 2019: 15 · 2018: 26 · 2017: 20 · 2016: 25 · 2015: 31 · 2014: 24 · 2013: 39 · 2012: 30
- FWCI
- 21.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Joslin Diabetes Center
- National Institutes of Health (5r01dk042539-08)
- Genentech
- National Institute of Diabetes and Digestive and Kidney Diseases (DK42539)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- insulin receptor tyrosine kinase, insulin resistance, TNF-α, obesity, type 2 diabetes, IRS-1, soluble TNF receptors, adipose tissue, skeletal muscle, adipocytes, glucose uptake, free fatty acids, plasma glucose, insulin, Zucker fatty rats
- MeSH terms
- Adipose Tissue, Animals, Diabetes Mellitus, Diabetes Mellitus, Type 2, Disease Models, Animal, Immunoglobulin G, Insulin, Insulin Resistance, Liver, Male, Muscles, Neutralization Tests, Obesity, Phosphoproteins, Phosphorylation, Protein-Tyrosine Kinases, Rats, Zucker, Receptor, Insulin, Recombinant Fusion Proteins, Specific Pathogen-Free Organisms, Tumor Necrosis Factor-alpha, Tyrosine, Receptors, Tumor Necrosis Factor, Phosphotyrosine, Rats, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review